JPRN-UMIN000002158尚未招募未知
Clinical study of MP plus zoledronic acid therapy in newly diagnosed multiple myeloma excluding stem cell transplantation patients - MP plus zoledronic acid therapy in newly diagnosed multiple myeloma
Division of clinial oncology and hematology, Jikei University School of Medicine0 个研究点目标入组 5 人开始时间: 2009年7月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Treatment history with bisphosphonate within 3 years. (2) Double cancer (or more) or cancer past history. (3)Uncontrollable any complication or infection. (4) Class III or IV heart disease by NYHA classification. (5) Under pregnancy, breast-feeding. (6) Dental infection (within 4 weeks after dental treatment). (7)Viral hepatitis (HBs antigen or HCV antibody positive) (8) Patient applied other clinical study. (9)Others (inappropriate case)
研究者
相似试验
已完成
2 期
Phase II study of zoledronic acid concomitant with androgen deprivation therapy for patients with treatment-naive bone-metastatic prostate cancerProstate cancerJPRN-UMIN000007548Kinki University52
招募中
2 期
A phase II clinical trial of zoledronic acid treatment for advanced non-small cell lung cancer with bone metastasis.on-small cell lung cancerJPRN-UMIN000006935Dokkyo Medical University School of Medicine, Department of Pulmonary Medicine and Clinical Immunology40
已完成
Unknown
A new study to minimise the side effects of rapid maxillary expansioSide effects of rapid maxillary expansion (RME) on dental and buccal alveolar bone changesOral HealthISRCTN16744226Damascus University32
已完成
3 期
Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With OsteoporosisOsteoporosisNCT00439244Novartis412
已完成
2 期
ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast CancerBreast CancerBreast DiseaseNeoplasmsNeoplasms by SiteNCT01472146Susanne Crocamo58